House ephedra hearings
This article was originally published in The Tan Sheet
Executive Summary
Energy & Commerce Committee ephedra investigation builds steam, with plans to hold two days of hearings in late July. Sports league heads, ephedra manufacturers, FDA reps likely will be called to testify. Committee chair Billy Tauzin (D-La.) and others send July 1 follow-up letter requesting FDA provide records on foreign ephedra investigations, AEs received since Sept. 30, 2001 close date of RAND report. Letter also requests records relating to FDA communications on the Boozer-Daly study often cited by ephedra proponents, and records relating to Hicksville, NY-based Phoenix Labs, which manufactured Xenadrine RFA-1 for Cytodyne. Investigation was launched in February with letters to McClellan, Cytodyne (1"The Tan Sheet" March 3, 2003, p. 9). Hearings for related inquiry into supplements marketed to children unlikely until after August recess...